Search

everythinglearnresearchcommunity

for

Search:↓

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Interest in new and personalized treatments for hair loss is growing.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

New genes linked to male pattern baldness were found on chromosome 20p11.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Effective PCOS treatments require targeting specific signaling pathways.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Genetic marker rs12558842 strongly linked to male hair loss.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Certain gene changes and hormone levels are linked to female hair loss.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Testosterone protects female heart cells from stress by activating estrogen receptors.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Both estrogens and androgens are important for health in both males and females.

Genetic differences affect how people respond to COVID-19.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.